Szabon A. Warfarin versus DOACs in the prevention of thromboembolic stroke in patients with Afib. : Warfarin versus DOACs in the prevention of thromboembolic stroke in patients with Afib. . JCANPA [Internet]. 2021 Jun. 19 [cited 2024 Nov. 24];3(7):p1-9. Available from: https://ojs.lib.umanitoba.ca/index.php/jcpa/article/view/900